ATE293167T1 - Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung - Google Patents

Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung

Info

Publication number
ATE293167T1
ATE293167T1 AT00967845T AT00967845T ATE293167T1 AT E293167 T1 ATE293167 T1 AT E293167T1 AT 00967845 T AT00967845 T AT 00967845T AT 00967845 T AT00967845 T AT 00967845T AT E293167 T1 ATE293167 T1 AT E293167T1
Authority
AT
Austria
Prior art keywords
ampk
coding sequences
dna coding
gamma variant
gamma
Prior art date
Application number
AT00967845T
Other languages
English (en)
Inventor
Leif Andersson
Christian Looft
Ernst Kalm
Denis Milan
Annie Robic
Claire Rogel-Gaillard
Nathalie Iannuccelli
Joel Gellin
Roy Pascale Le
Patrick Chardon
Original Assignee
Arexis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arexis Ab filed Critical Arexis Ab
Application granted granted Critical
Publication of ATE293167T1 publication Critical patent/ATE293167T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00967845T 1999-09-10 2000-09-11 Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung ATE293167T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99402236 1999-09-10
EP00401388 2000-05-18
PCT/EP2000/009896 WO2001020003A2 (en) 1999-09-10 2000-09-11 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof

Publications (1)

Publication Number Publication Date
ATE293167T1 true ATE293167T1 (de) 2005-04-15

Family

ID=26073491

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00967845T ATE293167T1 (de) 1999-09-10 2000-09-11 Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung

Country Status (15)

Country Link
US (1) US7462693B2 (de)
EP (1) EP1210441B1 (de)
JP (2) JP3983051B2 (de)
KR (1) KR100806954B1 (de)
CN (1) CN100439503C (de)
AT (1) ATE293167T1 (de)
AU (1) AU781744B2 (de)
BR (1) BR0013890A (de)
CA (1) CA2384313C (de)
DE (2) DE00967845T1 (de)
DK (1) DK1210441T3 (de)
ES (1) ES2239618T3 (de)
MX (1) MXPA02002613A (de)
PL (1) PL354753A1 (de)
WO (1) WO2001020003A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142310A1 (en) * 2000-04-07 2002-10-03 Leif Andersson Variants of the human AMP-activated protein kinase gamma 3 subunit
EP1354061A2 (de) 2000-09-08 2003-10-22 Iowa State University Research Foundation, Inc. Neue prkag3 allele und verwendungen derselben als genetische marker für reproduktivität- und fleisch-qualitätsmerkmale
US20060053499A1 (en) 2002-01-18 2006-03-09 Doris Kretzschmar An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
AU2003207884B2 (en) 2002-02-01 2008-07-31 Arexis Ab Variants of the alpha 1 subunit of human AMPK
WO2003064465A2 (en) * 2002-02-01 2003-08-07 Arexis Ab Prkag3 gene promoter and uses thereof
DE60331416D1 (de) * 2002-02-01 2010-04-08 Arexis Ab Transgene mäuse, die prkag3 exprimieren
GB0221148D0 (en) * 2002-09-12 2002-10-23 Univ Dundee Kinase inhibitor screening assay
US8688385B2 (en) * 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
CN104894239B (zh) * 2015-05-11 2017-12-19 中国农业科学院植物保护研究所 一种用AMPKγ基因评价昆虫发育速率的方法
CN113207808B (zh) * 2021-06-03 2023-09-29 贵州大学 一种柯乐猪的选育方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041156A (en) * 1974-11-08 1977-08-09 Mitsubishi Chemical Industries Limited N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4018915A (en) * 1976-01-05 1977-04-19 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4055651A (en) * 1974-11-08 1977-10-25 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4070457A (en) * 1974-11-08 1978-01-24 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4104392A (en) * 1974-11-08 1978-08-01 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof, and antithrombotic compositions and methods employing them
US4055636A (en) * 1974-11-08 1977-10-25 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4046876A (en) * 1974-11-08 1977-09-06 Mitsubishi Chemical Industries Limited N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4073914A (en) * 1974-11-08 1978-02-14 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4096255A (en) * 1974-11-08 1978-06-20 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides, and pharmaceutical salts, compositions and methods
US4036955A (en) * 1976-07-22 1977-07-19 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4018913A (en) * 1976-01-14 1977-04-19 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
AUPN745096A0 (en) * 1996-01-08 1996-02-01 St. Vincent's Institute Of Medical Research Novel amp activated protein kinase
US5885803A (en) * 1997-06-19 1999-03-23 Incyte Pharmaceuticals, Inc. Disease associated protein kinases
US20020142310A1 (en) 2000-04-07 2002-10-03 Leif Andersson Variants of the human AMP-activated protein kinase gamma 3 subunit
EP1354061A2 (de) 2000-09-08 2003-10-22 Iowa State University Research Foundation, Inc. Neue prkag3 allele und verwendungen derselben als genetische marker für reproduktivität- und fleisch-qualitätsmerkmale
WO2003064465A2 (en) 2002-02-01 2003-08-07 Arexis Ab Prkag3 gene promoter and uses thereof
AU2003207884B2 (en) 2002-02-01 2008-07-31 Arexis Ab Variants of the alpha 1 subunit of human AMPK
DE60331416D1 (de) 2002-02-01 2010-04-08 Arexis Ab Transgene mäuse, die prkag3 exprimieren

Also Published As

Publication number Publication date
DE60019433T2 (de) 2006-02-23
ES2239618T3 (es) 2005-10-01
AU7786400A (en) 2001-04-17
DE00967845T1 (de) 2004-07-08
CN100439503C (zh) 2008-12-03
KR20020062918A (ko) 2002-07-31
DE60019433D1 (de) 2005-05-19
AU781744B2 (en) 2005-06-09
WO2001020003A3 (en) 2001-05-17
CA2384313A1 (en) 2001-03-22
DK1210441T3 (da) 2005-07-04
MXPA02002613A (es) 2003-10-14
EP1210441A2 (de) 2002-06-05
JP2003509052A (ja) 2003-03-11
CA2384313C (en) 2010-10-19
US20070199081A1 (en) 2007-08-23
PL354753A1 (en) 2004-02-23
WO2001020003A2 (en) 2001-03-22
US7462693B2 (en) 2008-12-09
BR0013890A (pt) 2002-05-07
JP2007190021A (ja) 2007-08-02
CN1402787A (zh) 2003-03-12
KR100806954B1 (ko) 2008-02-22
JP3983051B2 (ja) 2007-09-26
EP1210441B1 (de) 2005-04-13

Similar Documents

Publication Publication Date Title
DK2333099T3 (da) Enzymer med alpha-amylase-aktivitet og fremgangsmåder til anvendelse deraf
ATE293167T1 (de) Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung
BR9913532A (pt) Novos inibidores heteroaromáticos de frutose 1,6-bifosfatase
EA200500019A1 (ru) Ксиланазы, кодирующие их нуклеиновые кислоты и способы их получения и применения
DE60236367D1 (de) Echolöscher, der eine weitere reduktion des restechos sicherstellt
TNSN05285A1 (en) Well treating method to prevent or cure lost-circulation
EP2327709A3 (de) Modulation der Glucagonrezeptorexpression
DE60007095T2 (de) Calanolide zur hemmung von btk
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
WO2004048534A3 (en) Modulation of cytokine-inducible kinase expression
DE60318391D1 (de) Bakteriophagen-lysin
BRPI0308119A2 (pt) microorganismo como portadores de seqüências de nucleotídeos codificando para antígenos de células para o tratamento de tumores.
ITSV20030016A1 (it) Sostanze contenenti tannini o miscele di tannini.
ITRM20030194A0 (it) Uso di derivati del 7-nitro-2,1,3-benzossadiazolo per la terapia di forme tumorali.
ATE335824T1 (de) Isolierte luziferasen sowie deren verwendung
DE602005016697D1 (de) Molekulardiagnoseverfahren und behandlung von demenz mit lewy-körperchen
NO20070780L (no) Celloverflateprotein.
DZ3174A1 (fr) Composition catalytique et procédé utilisant cettecomposition.
ITMO20030254A1 (it) Impianto per la concentrazione del succo di pomodoro.
IL169256A0 (en) Metalloprotease proteins
WO2004047741A3 (en) Modulation of iap-like expression
WO2004053083A3 (en) Modulation of fetoprotein transcription factor expression
GB0423126D0 (en) Protein
ITRM20000106A0 (it) Composizione per la prevenzione e/o il trattamento di vascolopatie, che comprende propionil l-carnitina e coenzima q10.
NO20045437L (no) Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1210441

Country of ref document: EP